| Company |
Trade Name |
Generic Name |
Action |
|
Acceleron Pharma Inc.
|
ACE-083
|
|
FDA granted orphan drug designation for the treatment of patients with Charcot-Marie-Tooth disease.
|
| Aerie Pharmaceuticals Inc. |
Rocklatan
|
|
FDA approved Rocklatan for the treatment of glaucoma.
|
|
Alkem Laboratories Ltd.
|
Valsartan
|
|
FDA approved a generic version of Diovan by Novartis for the treatment of high blood pressure and heart failure.
|
|
Amneal Pharmaceuticals Co.
|
Levomilnacipran extended-release capsules
|
|
FDA approved a generic version of Fetzima Extended-Release by Allergan for the treatment of Major Depressive Disorder.
|
|
Celgene
|
|
fedratinib |
FDA granted priority review for the treatment of myelofibrosis.
|
|
Espero BioPharma
|
Tecarfarin
|
|
FDA granted orphan drug designation for the prevention of systemic thromboembolism of cardiac origin in patients with end stage renal disease and atrial fibrillation.
|
|
Glenmark Pharmaceuticals Ltd.
|
|
sevelamer hydrochloride tablets
|
FDA approved a generic version of Renagel by Sanofi for the control of serum phosphorus in patients with chronic kidney disease on dialysis.
|
|
Janssen Pharmaceuticals Inc.
|
Spravato
|
esketamine nasal spray |
FDA approved Spravato in conjunction with an oral antidepressant, for the treatment of depression in adults who have tried other antidepressant medicines but have not benefited from them (treatment-resistant depression).
|
|
Micro Labs Limited, India
|
|
levofloxacin ophthalmic solution
|
FDA approved a generic version of Iquix by Vistakon Pharmaceuticals for the treatment of corneal ulcer caused by susceptible strains of specified bacteria.
|
|
Mitochon Pharmaceuticals
|
MP-101
|
|
FDA granted orphan drug designation for the treatment of Huntington disease.
|
|
Novitium Pharma LLC
|
|
pyridostigmine bromide syrup
|
FDA approved a generic version of Mestinon by Valeant Pharmaceuticals to improve muscle strength in patients with myasthenia gravis.
|
|
Perrigo UK FINCO Ltd.
|
|
acyclovir cream, 5%
|
FDA approved a generic version of Zovirax by GlaxoSmithKline for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adults and adolescents 12 years of age and older.
|
|
Pfizer
|
Trazimera
|
trastuzumab-qyyp |
FDA approved a biosimilar of Herceptin by Genentech for the treatment of human epidermal growth factor receptor-2 (HER2) overexpressing breast cancer and HER2 overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.
|
|
Roche
|
Tecentriq plus chemotherapy
|
atezolizumab plus Abraxane (paclitaxel protein-bound particles for injectable suspension [albumin-bound]; nab-paclitaxel) |
FDA approved the therapeutic for the treatment of adults with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) in people whose tumours express PD-L1.
|
|
Sanofi
|
Dupixent
|
dupilumab |
FDA approved Dupixent for the treatment of moderate-to-severe atopic dermatitis in adolescents.
|
|
Taro Pharmaceuticals Industries Ltd.
|
|
deferiprone tablets
|
FDA approved a generic version of Ferriprox by ApoPharma for the treatment of patients with transfusional iron overload due to thalassemia syndromes when current chelation therapy is inadequate.
|